Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix for Follicle Synchronisation in Oocyte Donors
NCT00434122Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Mar 2007
- Primary completion
- Dec 2007
- Modality
- Peptides, Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, single-blind trial of degarelix in female infertility (3 arms), sponsored by Ferring Pharmaceuticals. Primary endpoint: Coefficient of Variation of Follicular Sizes on Stimulation Day 1. Started Mar 2007; status: completed.
02
Drugs
degarelix
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT00434122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434122.